Oxygen Helium Mixture 20/80 Gas
NDC Package 17575-192-01
Package Information
Oxygen Helium Mixture 20/80 gases is a human prescription drug administered via respiratory (inhalation) route. This formulation utilizes a gas delivery system. Marketed by Agl Inhalation Therapy Co., this product is identified by NDC 17575-192 and is authorized under FDA application NDA205767.
Identification & Billing
- RxCUI: 413101 - oxygen 20 % Gas for Inhalation
- RxCUI: 413101 - nitrogen (inactive) 80 % / oxygen 20 % Gas for Inhalation
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17575 - Agl Inhalation Therapy Co.
- 17575-192 - Oxygen Helium Mixture 20/80
- 17575-192-01 - 4554 L in 1 CYLINDER
- 17575-192 - Oxygen Helium Mixture 20/80
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17575-192). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17575-192-01 identifies a specific commercial package of 4554 l in 1 cylinder of Oxygen Helium Mixture 20/80, a human prescription drug labeled by Agl Inhalation Therapy Co.. This gas is formulated for respiratory (inhalation) use and contains oxygen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Agl Inhalation Therapy Co. on January 01, 1966. The current certification is valid through December 31, 2027.
How is this Agl Inhalation Therapy Co. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17575019201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.